SLNSW-Severe refractory CIDP: a case series of 10 patie...-TN_cdi_proquest_journals_1936128059

Severe refractory CIDP: a case series of 10 patients treated with bortezomib

Full title: Severe refractory CIDP: a case series of 10 patients treated with bortezomib

Author/creator: Pitarokoili, Kalliopi, Yoon, Min-Suk, Kröger, Ilka, Reinacher-Schick, Anke, Gold, Ralf, Schneider-Gold, Christiane.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1936128059

Language: English

Formats: Articles

Publishers: Berlin/Heidelberg: Springer Berlin Heidelberg

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1936128059

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Severe refractory CIDP: a case series of 10 patients treated with bortezomib

    Record identifier

    TN_cdi_proquest_journals_1936128059

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1936128059

    Share

    Severe refractory CIDP: a case series of 10 patients treated with bortezomib

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1936128059

    Severe refractory CIDP: a case series of 10 patients treated with bortezomib

    Full title

    Severe refractory CIDP: a case series of 10 patients treated with bortezomib

    Author / Creator

    Pitarokoili, Kalliopi ; Yoon, Min-Suk ; Kröger, Ilka ; Reinacher-Schick, Anke ; Gold, Ralf ; Schneider-Gold, Christiane

    Publisher

    Berlin/Heidelberg: Springer Berlin Heidelberg

    Journal title

    Journal of neurology, 2017, Vol.264 (9), p.2010-2020

    Record Identifier

    TN_cdi_proquest_journals_1936128059

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Aged Antigens, CD20 - immunology Antineoplastic Agents - therapeutic use Autografts Bortezomib Bortezomib - therapeutic use CD20 antigen Chronic inflammatory demyelinating polyradiculoneuropathy Complications and side effects Cyclophosphamide Demyelination Dosage and administration Dose-Response Relationship, Drug Drug therapy Female Follow-Up Studies Humans Immunoglobulins, Intravenous Immunosuppression Inflammation Male Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Neurology Neuropathy Neuroradiology Neurosciences Original Communication Peripheral blood Plasma cells Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy Proteasomes Retrospective Studies Rituximab Side effects Stem cell transplantation Transplantation Treatment Outcome Young Adult

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1936128059

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1936128059

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections